MAR 07, 2017 10:09 AM PST

Red Blood Cells Equipped to Carry Autoimmune Disease Treatments

WRITTEN BY: Kara Marker

Researchers are “hijacking” red blood cells because of their ability to flow freely in and out of nearly all types of body tissues without being noticed by the immune system. By attaching proteins to the red blood cell surface, a team from the Whitehead Institute of Biomedical Research developed a new technique for desensitizing the immune system.

Red blood cells are the most common type of blood cell.

Autoimmune diseases like rheumatoid arthritis, multiple sclerosis (MS), and type 1 diabetes occur because of the immune system’s reaction to certain proteins as if they were foreign antigens, substances produced by pathogens that stimulate an immune response. However, in a new study published in the journal Proceedings of the National Academy of Sciences, researchers worked with red blood cells to suppress the immune response to these harmless proteins.

"Essentially what we're doing is hijacking the red blood cell clearance pathway, such that the foreign antigen masquerades as the red blood cells' own, such that these antigens are being tolerated in the process," explained MIT graduate student Novalia Pishesha.

Immunosuppressants are the typical option used to treat autoimmune diseases, which the National Institutes of Health estimate influence the lives of more than 23 million Americans. Immunosuppressants successfully regulate the immune response but also make an individual especially prone to infections. The new approach presents a new way to avoid the infection vulnerability: tolerance induction.

Tolerance induction involves taking peptides from antigens as a way to “retrain” the immune system to know when and when not to react. However, delivering the antigenic peptides to where they need to go without being attacked by the immune system poses a serious problem.

Scientists from the Whitehead Institute of Biomedical Research, during their study of red blood cells as potential vessels for carrying antigenic peptides, quickly saw the benefits of using these cells to carry immune-sensitizing proteins. Red blood cells regularly access nearly every type of tissue in the body, and they are recycled regularly without triggering an immune response against them.

Previous research from the same group involved tagging red blood cells with biotin, a B vitamin, and antibodies, via a technique called “sortagging.” Their present study involved early stage mouse models of autoimmune disease. They paired a sample of blood cells with antigens that prompt MS and type 1 diabetes and then transfused the cells back into the mice models. The process takes less than an hour, and researchers saw an immediate reduction in disease symptoms and prevention of further symptoms.

"If this type of response is also true in humans, then it could make a lot of these therapies possible for these diseases and similar conditions,” said MIT Professor Harvey Lodish.

Source: Whitehead Institute of Biomedical Research

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 26, 2018
Videos
SEP 26, 2018
Cancer Immunotherapy
Video illustration about how tumor cells are sensed and destroyed by the immune system and how tumors evolve and detect immune-mediated eliminations, as well as iimmunotherapies associated....
OCT 01, 2018
Immunology
OCT 01, 2018
Fate of the T Cell
The immune system consists of a variety of different cell types. But how do the cells undergo differentiation? A study recently published in Science provides insight....
OCT 23, 2018
Immunology
OCT 23, 2018
Missense Immune Disruption
A point mutation has caused a de novo immune deficiency observed in two patients...
NOV 14, 2018
Immunology
NOV 14, 2018
Reversing T Cell dysfunction in Cancer: Getting the Body to Fight its own Battles
Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy,...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
DEC 08, 2018
Health & Medicine
DEC 08, 2018
Chronic Fatigue: Where Are We in Our Understanding?
  Ask anyone who suffers from an autoimmune disease or fibromyalgia about the most challenging aspect of their condition, and the answer will be unani...
Loading Comments...